chr1-202967201-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_016243.3(CYB5R1):c.5G>A(p.Gly2Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000366 in 1,611,908 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_016243.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYB5R1 | NM_016243.3 | c.5G>A | p.Gly2Glu | missense_variant | 1/9 | ENST00000367249.9 | NP_057327.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYB5R1 | ENST00000367249.9 | c.5G>A | p.Gly2Glu | missense_variant | 1/9 | 1 | NM_016243.3 | ENSP00000356218.4 | ||
CYB5R1 | ENST00000473599.5 | n.75G>A | non_coding_transcript_exon_variant | 1/5 | 3 | |||||
CYB5R1 | ENST00000478009.1 | n.25G>A | non_coding_transcript_exon_variant | 1/3 | 2 | |||||
CYB5R1 | ENST00000482572.5 | n.43G>A | non_coding_transcript_exon_variant | 1/8 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000198 AC: 3AN: 151820Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000928 AC: 23AN: 247778Hom.: 0 AF XY: 0.000126 AC XY: 17AN XY: 134442
GnomAD4 exome AF: 0.0000384 AC: 56AN: 1459970Hom.: 1 Cov.: 32 AF XY: 0.0000578 AC XY: 42AN XY: 726274
GnomAD4 genome AF: 0.0000197 AC: 3AN: 151938Hom.: 0 Cov.: 31 AF XY: 0.0000404 AC XY: 3AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 05, 2024 | The c.5G>A (p.G2E) alteration is located in exon 1 (coding exon 1) of the CYB5R1 gene. This alteration results from a G to A substitution at nucleotide position 5, causing the glycine (G) at amino acid position 2 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at